ABAXIS INC Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 26 rows in 2007. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2007-10-29: Reporting owner WOOD DONALD PETER; Form 4; Security Restricted Stock Units; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-05-15: Reporting owner SEVERSON CLINTON; Form 4; Security Restricted Stock Units; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-05-15: Reporting owner OSTOICH VLADIMIR; Form 4; Security Restricted Stock Unit; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-05-15: Reporting owner Mulroy Martin; Form 4; Security Restricted Stock Units; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2007-10-29 | WOOD DONALD PETER Officer (VP of Operations) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $0.00 | 2007-11-07 | |
| 2007-05-15 | SEVERSON CLINTON Director, Officer (President,CEO & Board Chairman) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 721,537 owned after | $0.00 | 2007-05-16 | |
| 2007-05-15 | OSTOICH VLADIMIR Officer (VP of Govt Affairs & Pac Rim) | 4 | Restricted Stock Unit Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 442,380 owned after | $0.00 | 2007-05-16 | |
| 2007-05-15 | Mulroy Martin Officer (VP-Sales&Marketing,Veterinary) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 25,746 owned after | $0.00 | 2007-05-16 | |
| 2007-05-15 | Bernard Christopher Officer (VP of Medical Sales and Mktg) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 642 owned after | $0.00 | 2007-05-16 | |
| 2007-05-15 | MILDER ROBERT Officer (Chief Operations Officer) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 127,805 owned after | $0.00 | 2007-05-16 | |
| 2007-05-15 | ARON KENNETH Officer (VP of Research and Development) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 146,980 owned after | $0.00 | 2007-05-16 | |
| 2007-05-15 | INES ALBERTO SANTA Officer (CFO and VP of Finance) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 169,647 owned after | $0.00 | 2007-05-16 | |
| 2007-05-15 | TUCKER ERNEST Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500 22,000 owned after | $0.00 | 2007-05-16 | |
| 2007-05-15 | SINGH PRITHIPAL Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500 32,500 owned after | $0.00 | 2007-05-16 | |
| 2007-05-15 | BASTIANI RICHARD Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500 76,500 owned after | $0.00 | 2007-05-16 | |
| 2007-05-15 | HANLON BRENTON Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500 34,500 owned after | $0.00 | 2007-05-16 | |
| 2007-05-15 | EVENHUIS HENK Director | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500 19,500 owned after | $0.00 | 2007-05-16 | |
| 2007-04-30 | SEVERSON CLINTON Officer (President,CEO & Board Chairman) | 4/A | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 721,537 owned after | $0.00 | 2007-05-03 | |
| 2007-04-30 | SEVERSON CLINTON Officer (President,CEO & Board Chairman) | 4/A | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 721,537 owned after | $0.00 | 2007-05-03 | |
| 2007-04-30 | OSTOICH VLADIMIR Officer (VP of Govt Affairs & Pac Rim) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 448,380 owned after | $0.00 | 2007-05-02 | |
| 2007-04-30 | INES ALBERTO SANTA Officer (CFO and VP of Finance) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 171,647 owned after | $0.00 | 2007-05-02 | |
| 2007-04-30 | MILDER ROBERT Officer (Chief Operations Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 127,805 owned after | $0.00 | 2007-05-02 | |
| 2007-04-30 | ARON KENNETH Officer (VP of Research and Development) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 146,980 owned after | $0.00 | 2007-05-02 | |
| 2007-04-30 | Mulroy Martin Officer (VP of Veterinary Sales & Mktg) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 30,180 owned after | $0.00 | 2007-05-02 | |
| 2007-04-30 | Bernard Christopher Officer (VP of Medical Sales and Mktg) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 642 owned after | $0.00 | 2007-05-02 | |
| 2007-04-30 | TUCKER ERNEST Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 23,500 owned after | $0.00 | 2007-05-02 | |
| 2007-04-30 | SINGH PRITHIPAL Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 32,500 owned after | $0.00 | 2007-05-02 | |
| 2007-04-30 | EVENHUIS HENK Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 19,500 owned after | $0.00 | 2007-05-02 | |
| 2007-04-30 | BASTIANI RICHARD Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 76,500 owned after | $0.00 | 2007-05-02 | |
| 2007-04-30 | HANLON BRENTON Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 34,500 owned after | $0.00 | 2007-05-02 |